nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—LTK—mouth—Behcet's disease	0.042	0.0471	CbGeAlD
Erlotinib—ULK3—mouth—Behcet's disease	0.0228	0.0256	CbGeAlD
Erlotinib—TNK1—mammalian vulva—Behcet's disease	0.0156	0.0175	CbGeAlD
Erlotinib—PIP4K2C—retina—Behcet's disease	0.0151	0.0169	CbGeAlD
Erlotinib—ULK3—eye—Behcet's disease	0.0145	0.0163	CbGeAlD
Erlotinib—ULK3—retina—Behcet's disease	0.0144	0.0162	CbGeAlD
Erlotinib—MKNK1—eye—Behcet's disease	0.0137	0.0153	CbGeAlD
Erlotinib—MKNK1—retina—Behcet's disease	0.0135	0.0152	CbGeAlD
Erlotinib—EGFR—mammalian vulva—Behcet's disease	0.0125	0.014	CbGeAlD
Erlotinib—AURKC—nervous system—Behcet's disease	0.0124	0.0139	CbGeAlD
Erlotinib—PIP4K2C—mammalian vulva—Behcet's disease	0.0121	0.0136	CbGeAlD
Erlotinib—AURKC—central nervous system—Behcet's disease	0.0119	0.0134	CbGeAlD
Erlotinib—PIP4K2C—cardiac atrium—Behcet's disease	0.0116	0.013	CbGeAlD
Erlotinib—ULK3—mammalian vulva—Behcet's disease	0.0115	0.0129	CbGeAlD
Erlotinib—JAK3—nervous system—Behcet's disease	0.0115	0.0129	CbGeAlD
Erlotinib—EPHA6—nervous system—Behcet's disease	0.0115	0.0129	CbGeAlD
Erlotinib—HIPK4—brain—Behcet's disease	0.0111	0.0125	CbGeAlD
Erlotinib—JAK3—central nervous system—Behcet's disease	0.0111	0.0124	CbGeAlD
Erlotinib—EPHA6—central nervous system—Behcet's disease	0.0111	0.0124	CbGeAlD
Erlotinib—ULK3—cardiac atrium—Behcet's disease	0.011	0.0124	CbGeAlD
Erlotinib—LTK—brain—Behcet's disease	0.011	0.0123	CbGeAlD
Erlotinib—PIP4K2C—medulla oblongata—Behcet's disease	0.0109	0.0122	CbGeAlD
Erlotinib—MKNK1—mammalian vulva—Behcet's disease	0.0108	0.0122	CbGeAlD
Erlotinib—MAP3K19—nervous system—Behcet's disease	0.0104	0.0117	CbGeAlD
Erlotinib—ULK3—medulla oblongata—Behcet's disease	0.0104	0.0117	CbGeAlD
Erlotinib—MKNK1—cardiac atrium—Behcet's disease	0.0104	0.0117	CbGeAlD
Erlotinib—MAP2K5—brainstem—Behcet's disease	0.0103	0.0116	CbGeAlD
Erlotinib—SLK—mammalian vulva—Behcet's disease	0.0103	0.0115	CbGeAlD
Erlotinib—MAP3K19—central nervous system—Behcet's disease	0.0101	0.0113	CbGeAlD
Erlotinib—PIP4K2C—midbrain—Behcet's disease	0.00996	0.0112	CbGeAlD
Erlotinib—SLK—cardiac atrium—Behcet's disease	0.00984	0.011	CbGeAlD
Erlotinib—MKNK1—medulla oblongata—Behcet's disease	0.00979	0.011	CbGeAlD
Erlotinib—PIP4K2C—spinal cord—Behcet's disease	0.00972	0.0109	CbGeAlD
Erlotinib—ULK3—midbrain—Behcet's disease	0.00951	0.0107	CbGeAlD
Erlotinib—AURKC—brain—Behcet's disease	0.00948	0.0106	CbGeAlD
Erlotinib—ULK3—spinal cord—Behcet's disease	0.00928	0.0104	CbGeAlD
Erlotinib—SLK—medulla oblongata—Behcet's disease	0.00927	0.0104	CbGeAlD
Erlotinib—MKNK1—midbrain—Behcet's disease	0.00895	0.01	CbGeAlD
Erlotinib—STK10—mammalian vulva—Behcet's disease	0.00893	0.01	CbGeAlD
Erlotinib—EPHA6—brain—Behcet's disease	0.00878	0.00986	CbGeAlD
Erlotinib—JAK3—brain—Behcet's disease	0.00878	0.00986	CbGeAlD
Erlotinib—MKNK1—spinal cord—Behcet's disease	0.00873	0.0098	CbGeAlD
Erlotinib—SLK—midbrain—Behcet's disease	0.00848	0.00952	CbGeAlD
Erlotinib—SLK—spinal cord—Behcet's disease	0.00827	0.00928	CbGeAlD
Erlotinib—PIP4K2C—nervous system—Behcet's disease	0.00819	0.00919	CbGeAlD
Erlotinib—TNK1—brain—Behcet's disease	0.00806	0.00905	CbGeAlD
Erlotinib—MAP3K19—brain—Behcet's disease	0.00798	0.00896	CbGeAlD
Erlotinib—MAP2K5—mammalian vulva—Behcet's disease	0.00798	0.00896	CbGeAlD
Erlotinib—ABL1—brainstem—Behcet's disease	0.00797	0.00894	CbGeAlD
Erlotinib—PIP4K2C—central nervous system—Behcet's disease	0.00788	0.00885	CbGeAlD
Erlotinib—ULK3—nervous system—Behcet's disease	0.00782	0.00878	CbGeAlD
Erlotinib—ABL1—eye—Behcet's disease	0.00776	0.00871	CbGeAlD
Erlotinib—ABL1—retina—Behcet's disease	0.00769	0.00863	CbGeAlD
Erlotinib—MAP2K5—cardiac atrium—Behcet's disease	0.00764	0.00858	CbGeAlD
Erlotinib—ULK3—central nervous system—Behcet's disease	0.00753	0.00845	CbGeAlD
Erlotinib—MKNK1—nervous system—Behcet's disease	0.00736	0.00826	CbGeAlD
Erlotinib—CYP1A1—mouth—Behcet's disease	0.0073	0.0082	CbGeAlD
Erlotinib—MAP2K5—medulla oblongata—Behcet's disease	0.0072	0.00808	CbGeAlD
Erlotinib—MKNK1—central nervous system—Behcet's disease	0.00708	0.00795	CbGeAlD
Erlotinib—ABL1—skin of body—Behcet's disease	0.00675	0.00758	CbGeAlD
Erlotinib—ABL2—brain—Behcet's disease	0.00661	0.00743	CbGeAlD
Erlotinib—MAP2K5—midbrain—Behcet's disease	0.00658	0.00739	CbGeAlD
Erlotinib—CYP1B1—eye—Behcet's disease	0.00657	0.00737	CbGeAlD
Erlotinib—EGFR—brain—Behcet's disease	0.00646	0.00725	CbGeAlD
Erlotinib—MAP2K5—spinal cord—Behcet's disease	0.00642	0.00721	CbGeAlD
Erlotinib—PIP4K2C—brain—Behcet's disease	0.00626	0.00703	CbGeAlD
Erlotinib—ABL1—mammalian vulva—Behcet's disease	0.00615	0.00691	CbGeAlD
Erlotinib—STK10—nervous system—Behcet's disease	0.00606	0.0068	CbGeAlD
Erlotinib—ULK3—brain—Behcet's disease	0.00598	0.00671	CbGeAlD
Erlotinib—ABL1—cardiac atrium—Behcet's disease	0.00589	0.00662	CbGeAlD
Erlotinib—STK10—central nervous system—Behcet's disease	0.00583	0.00655	CbGeAlD
Erlotinib—CYP1B1—skin of body—Behcet's disease	0.00571	0.00642	CbGeAlD
Erlotinib—MKNK1—brain—Behcet's disease	0.00562	0.00631	CbGeAlD
Erlotinib—SLCO2B1—medulla oblongata—Behcet's disease	0.0056	0.00629	CbGeAlD
Erlotinib—ABL1—medulla oblongata—Behcet's disease	0.00556	0.00624	CbGeAlD
Erlotinib—MAP2K5—nervous system—Behcet's disease	0.00541	0.00607	CbGeAlD
Erlotinib—SLK—brain—Behcet's disease	0.00533	0.00598	CbGeAlD
Erlotinib—ORM1—spinal cord—Behcet's disease	0.00521	0.00585	CbGeAlD
Erlotinib—MAP2K5—central nervous system—Behcet's disease	0.00521	0.00585	CbGeAlD
Erlotinib—ABL1—midbrain—Behcet's disease	0.00508	0.0057	CbGeAlD
Erlotinib—SLCO2B1—spinal cord—Behcet's disease	0.005	0.00561	CbGeAlD
Erlotinib—ABL1—spinal cord—Behcet's disease	0.00495	0.00556	CbGeAlD
Erlotinib—STK10—brain—Behcet's disease	0.00463	0.0052	CbGeAlD
Erlotinib—ABCB1—blood vessel—Behcet's disease	0.00453	0.00509	CbGeAlD
Erlotinib—ORM1—nervous system—Behcet's disease	0.00439	0.00493	CbGeAlD
Erlotinib—ORM1—central nervous system—Behcet's disease	0.00423	0.00475	CbGeAlD
Erlotinib—SLCO2B1—nervous system—Behcet's disease	0.00421	0.00473	CbGeAlD
Erlotinib—ABL1—nervous system—Behcet's disease	0.00417	0.00469	CbGeAlD
Erlotinib—MAP2K5—brain—Behcet's disease	0.00414	0.00464	CbGeAlD
Erlotinib—SLCO2B1—central nervous system—Behcet's disease	0.00405	0.00455	CbGeAlD
Erlotinib—CYP1A1—skin of body—Behcet's disease	0.00404	0.00454	CbGeAlD
Erlotinib—ABL1—central nervous system—Behcet's disease	0.00402	0.00451	CbGeAlD
Erlotinib—ABCG2—mammalian vulva—Behcet's disease	0.00388	0.00436	CbGeAlD
Erlotinib—CYP1A1—mammalian vulva—Behcet's disease	0.00368	0.00414	CbGeAlD
Erlotinib—CYP1B1—nervous system—Behcet's disease	0.00354	0.00397	CbGeAlD
Erlotinib—CYP1A1—cardiac atrium—Behcet's disease	0.00353	0.00396	CbGeAlD
Erlotinib—ABCG2—medulla oblongata—Behcet's disease	0.0035	0.00393	CbGeAlD
Erlotinib—CYP2D6—brainstem—Behcet's disease	0.00344	0.00387	CbGeAlD
Erlotinib—CYP1B1—central nervous system—Behcet's disease	0.0034	0.00382	CbGeAlD
Erlotinib—SLCO2B1—brain—Behcet's disease	0.00322	0.00361	CbGeAlD
Erlotinib—ABCG2—midbrain—Behcet's disease	0.0032	0.00359	CbGeAlD
Erlotinib—ABL1—brain—Behcet's disease	0.00319	0.00358	CbGeAlD
Erlotinib—ABCG2—spinal cord—Behcet's disease	0.00312	0.00351	CbGeAlD
Erlotinib—ALB—brain—Behcet's disease	0.00294	0.00331	CbGeAlD
Erlotinib—CYP1B1—brain—Behcet's disease	0.0027	0.00303	CbGeAlD
Erlotinib—CYP1A1—nervous system—Behcet's disease	0.0025	0.00281	CbGeAlD
Erlotinib—CYP1A1—central nervous system—Behcet's disease	0.00241	0.0027	CbGeAlD
Erlotinib—ABCB1—retina—Behcet's disease	0.00239	0.00268	CbGeAlD
Erlotinib—CYP2C8—brain—Behcet's disease	0.00207	0.00232	CbGeAlD
Erlotinib—ABCG2—brain—Behcet's disease	0.00201	0.00226	CbGeAlD
Erlotinib—ABCB1—mammalian vulva—Behcet's disease	0.00191	0.00215	CbGeAlD
Erlotinib—CYP1A1—brain—Behcet's disease	0.00191	0.00214	CbGeAlD
Erlotinib—CYP3A4—nervous system—Behcet's disease	0.00183	0.00206	CbGeAlD
Erlotinib—CYP2D6—nervous system—Behcet's disease	0.0018	0.00203	CbGeAlD
Erlotinib—CYP3A4—central nervous system—Behcet's disease	0.00177	0.00198	CbGeAlD
Erlotinib—CYP2D6—central nervous system—Behcet's disease	0.00174	0.00195	CbGeAlD
Erlotinib—ABCB1—medulla oblongata—Behcet's disease	0.00173	0.00194	CbGeAlD
Erlotinib—ABCB1—midbrain—Behcet's disease	0.00158	0.00177	CbGeAlD
Erlotinib—ABCB1—spinal cord—Behcet's disease	0.00154	0.00173	CbGeAlD
Erlotinib—ALB—HDL-mediated lipid transport—APOA1—Behcet's disease	0.00143	0.0131	CbGpPWpGaD
Erlotinib—MAP2K5—Focal Adhesion—ITGAL—Behcet's disease	0.00139	0.0127	CbGpPWpGaD
Erlotinib—JAK3—Oncostatin M Signaling Pathway—SERPINE1—Behcet's disease	0.00139	0.0127	CbGpPWpGaD
Erlotinib—CYP2D6—brain—Behcet's disease	0.00138	0.00155	CbGeAlD
Erlotinib—CYP1B1—Tryptophan metabolism—CAT—Behcet's disease	0.00135	0.0124	CbGpPWpGaD
Erlotinib—ABCB1—nervous system—Behcet's disease	0.0013	0.00146	CbGeAlD
Erlotinib—EGFR—Syndecan-3-mediated signaling events—CXCL8—Behcet's disease	0.00127	0.0117	CbGpPWpGaD
Erlotinib—ABCB1—central nervous system—Behcet's disease	0.00125	0.0014	CbGeAlD
Erlotinib—CYP1A1—Oxidative Stress—CAT—Behcet's disease	0.00117	0.0107	CbGpPWpGaD
Erlotinib—ALB—Lipoprotein metabolism—APOB—Behcet's disease	0.00104	0.00949	CbGpPWpGaD
Erlotinib—ABCB1—brain—Behcet's disease	0.000992	0.00111	CbGeAlD
Erlotinib—ABCB1—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.000974	0.00892	CbGpPWpGaD
Erlotinib—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—Behcet's disease	0.000955	0.00874	CbGpPWpGaD
Erlotinib—EGFR—Bladder Cancer—CXCL8—Behcet's disease	0.000932	0.00854	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—ITGB2—Behcet's disease	0.000865	0.00792	CbGpPWpGaD
Erlotinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—Behcet's disease	0.000864	0.00791	CbGpPWpGaD
Erlotinib—CYP1A1—Tryptophan metabolism—CAT—Behcet's disease	0.000832	0.00762	CbGpPWpGaD
Erlotinib—EGFR—Focal Adhesion—ITGB2—Behcet's disease	0.000828	0.00758	CbGpPWpGaD
Erlotinib—EGFR—Thromboxane A2 receptor signaling—ICAM1—Behcet's disease	0.000821	0.00752	CbGpPWpGaD
Erlotinib—ALB—Lipoprotein metabolism—APOA1—Behcet's disease	0.00082	0.00751	CbGpPWpGaD
Erlotinib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOB—Behcet's disease	0.000807	0.00739	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—ITGAL—Behcet's disease	0.00078	0.00714	CbGpPWpGaD
Erlotinib—ABL1—DNA Damage Response (only ATM dependent)—CAT—Behcet's disease	0.000773	0.00708	CbGpPWpGaD
Erlotinib—MAP2K5—Cardiac Hypertrophic Response—TNF—Behcet's disease	0.000765	0.007	CbGpPWpGaD
Erlotinib—EGFR—Focal Adhesion—ITGAL—Behcet's disease	0.000747	0.00684	CbGpPWpGaD
Erlotinib—ALB—Lipid and lipoprotein metabolism—APOB—Behcet's disease	0.000689	0.00631	CbGpPWpGaD
Erlotinib—JAK3—Immune System—MEFV—Behcet's disease	0.000688	0.0063	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—APOB—Behcet's disease	0.000678	0.00621	CbGpPWpGaD
Erlotinib—JAK3—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000659	0.00603	CbGpPWpGaD
Erlotinib—EGFR—Thromboxane A2 receptor signaling—NOS3—Behcet's disease	0.000655	0.006	CbGpPWpGaD
Erlotinib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—Behcet's disease	0.000639	0.00585	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.000638	0.00584	CbGpPWpGaD
Erlotinib—EGFR—SHP2 signaling—NOS3—Behcet's disease	0.000637	0.00583	CbGpPWpGaD
Erlotinib—ABCB1—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.000621	0.00569	CbGpPWpGaD
Erlotinib—JAK3—Immune System—ERAP1—Behcet's disease	0.000613	0.00561	CbGpPWpGaD
Erlotinib—ABL1—p73 transcription factor network—SERPINE1—Behcet's disease	0.00061	0.00558	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—MEFV—Behcet's disease	0.000605	0.00554	CbGpPWpGaD
Erlotinib—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—Behcet's disease	0.000604	0.00553	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—CCR1—Behcet's disease	0.000575	0.00526	CbGpPWpGaD
Erlotinib—EGFR—AGE/RAGE pathway—NOS3—Behcet's disease	0.000574	0.00526	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—CAT—Behcet's disease	0.000568	0.0052	CbGpPWpGaD
Erlotinib—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.000562	0.00514	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—APOB—Behcet's disease	0.000552	0.00505	CbGpPWpGaD
Erlotinib—ALB—Lipid and lipoprotein metabolism—APOA1—Behcet's disease	0.000545	0.00499	CbGpPWpGaD
Erlotinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TNF—Behcet's disease	0.000545	0.00499	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—APOA1—Behcet's disease	0.000537	0.00491	CbGpPWpGaD
Erlotinib—CYP1A2—Tryptophan metabolism—CAT—Behcet's disease	0.000531	0.00486	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—CTLA4—Behcet's disease	0.000524	0.00479	CbGpPWpGaD
Erlotinib—JAK3—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000523	0.00479	CbGpPWpGaD
Erlotinib—EGFR—LPA receptor mediated events—CXCL8—Behcet's disease	0.000522	0.00478	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CCR1—Behcet's disease	0.000522	0.00478	CbGpPWpGaD
Erlotinib—MAP2K5—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.000522	0.00478	CbGpPWpGaD
Erlotinib—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000521	0.00477	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000518	0.00474	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—MEFV—Behcet's disease	0.000517	0.00473	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—ICAM1—Behcet's disease	0.00051	0.00467	CbGpPWpGaD
Erlotinib—MKNK1—MAPK Signaling Pathway—TNF—Behcet's disease	0.000509	0.00466	CbGpPWpGaD
Erlotinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—Behcet's disease	0.000495	0.00453	CbGpPWpGaD
Erlotinib—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000486	0.00445	CbGpPWpGaD
Erlotinib—CYP1B1—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.000486	0.00445	CbGpPWpGaD
Erlotinib—EGFR—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.000473	0.00433	CbGpPWpGaD
Erlotinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000473	0.00433	CbGpPWpGaD
Erlotinib—JAK3—Immune System—ITGB2—Behcet's disease	0.000453	0.00415	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—ICAM1—Behcet's disease	0.000452	0.00414	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—CAT—Behcet's disease	0.000451	0.00413	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—ITGB2—Behcet's disease	0.000443	0.00405	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—ERAP1—Behcet's disease	0.000442	0.00405	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—APOB—Behcet's disease	0.000438	0.00401	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—APOA1—Behcet's disease	0.000437	0.004	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—APOB—Behcet's disease	0.000429	0.00393	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—SERPINE1—Behcet's disease	0.000426	0.0039	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—ICAM1—Behcet's disease	0.000415	0.0038	CbGpPWpGaD
Erlotinib—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	0.00041	0.00375	CbGpPWpGaD
Erlotinib—JAK3—Immune System—ITGAL—Behcet's disease	0.000409	0.00375	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CCR1—Behcet's disease	0.000409	0.00374	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—IL10—Behcet's disease	0.000407	0.00373	CbGpPWpGaD
Erlotinib—EGFR—DAP12 interactions—HLA-B—Behcet's disease	0.000403	0.00369	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—ITGAL—Behcet's disease	0.000399	0.00366	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—ITGB2—Behcet's disease	0.000399	0.00365	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—HLA-B—Behcet's disease	0.000387	0.00355	CbGpPWpGaD
Erlotinib—ALB—Platelet degranulation—APOA1—Behcet's disease	0.000374	0.00343	CbGpPWpGaD
Erlotinib—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.000357	0.00326	CbGpPWpGaD
Erlotinib—ABL1—Immune System—MEFV—Behcet's disease	0.000352	0.00322	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—APOA1—Behcet's disease	0.000347	0.00317	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—SERPINE1—Behcet's disease	0.000347	0.00317	CbGpPWpGaD
Erlotinib—NR1I2—Generic Transcription Pathway—SERPINE1—Behcet's disease	0.000343	0.00314	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—ITGB2—Behcet's disease	0.000341	0.00312	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—APOA1—Behcet's disease	0.00034	0.00311	CbGpPWpGaD
Erlotinib—EGFR—Direct p53 effectors—SERPINE1—Behcet's disease	0.00033	0.00302	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.000329	0.00302	CbGpPWpGaD
Erlotinib—ABL1—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.000328	0.003	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—ITGB2—Behcet's disease	0.000327	0.00299	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—CXCL8—Behcet's disease	0.00032	0.00293	CbGpPWpGaD
Erlotinib—CYP1A1—PPARA activates gene expression—APOA1—Behcet's disease	0.000318	0.00291	CbGpPWpGaD
Erlotinib—ABL1—Immune System—ERAP1—Behcet's disease	0.000314	0.00287	CbGpPWpGaD
Erlotinib—MAP2K5—MAPK Signaling Pathway—TNF—Behcet's disease	0.000313	0.00286	CbGpPWpGaD
Erlotinib—SLCO2B1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000312	0.00286	CbGpPWpGaD
Erlotinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—Behcet's disease	0.000311	0.00285	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CCR1—Behcet's disease	0.000308	0.00282	CbGpPWpGaD
Erlotinib—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.000304	0.00278	CbGpPWpGaD
Erlotinib—EGFR—Immune System—MEFV—Behcet's disease	0.000301	0.00275	CbGpPWpGaD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000299	0.00274	CbGpPWpGaD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.000299	0.00274	CbGpPWpGaD
Erlotinib—ALB—Platelet degranulation—SERPINE1—Behcet's disease	0.000297	0.00272	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—ITGAL—Behcet's disease	0.000295	0.0027	CbGpPWpGaD
Erlotinib—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.000283	0.00259	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CTLA4—Behcet's disease	0.000281	0.00258	CbGpPWpGaD
Erlotinib—EGFR—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.00028	0.00256	CbGpPWpGaD
Erlotinib—MKNK1—Disease—APOB—Behcet's disease	0.000276	0.00252	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.000275	0.00252	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—SERPINE1—Behcet's disease	0.00027	0.00247	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ERAP1—Behcet's disease	0.000268	0.00246	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—NOS3—Behcet's disease	0.000257	0.00236	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCR1—Behcet's disease	0.000251	0.0023	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—TNF—Behcet's disease	0.000251	0.0023	CbGpPWpGaD
Erlotinib—SLCO2B1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000247	0.00226	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—TNF—Behcet's disease	0.000235	0.00215	CbGpPWpGaD
Erlotinib—ABL1—Immune System—ITGB2—Behcet's disease	0.000232	0.00213	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCR1—Behcet's disease	0.000228	0.00209	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—TNF—Behcet's disease	0.000223	0.00204	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	0.000223	0.00204	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—APOB—Behcet's disease	0.00022	0.00201	CbGpPWpGaD
Erlotinib—MKNK1—Disease—APOA1—Behcet's disease	0.000218	0.002	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—ITGB2—Behcet's disease	0.000218	0.002	CbGpPWpGaD
Erlotinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—Behcet's disease	0.000215	0.00196	CbGpPWpGaD
Erlotinib—ABL1—Immune System—ITGAL—Behcet's disease	0.000209	0.00192	CbGpPWpGaD
Erlotinib—JAK3—Immune System—HLA-B—Behcet's disease	0.000208	0.00191	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—TNF—Behcet's disease	0.000204	0.00187	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CTLA4—Behcet's disease	0.000203	0.00186	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ITGB2—Behcet's disease	0.000198	0.00182	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—TNF—Behcet's disease	0.000198	0.00181	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—ITGAL—Behcet's disease	0.000197	0.0018	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—APOB—Behcet's disease	0.000193	0.00177	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000191	0.00175	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.000191	0.00175	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—HLA-B—Behcet's disease	0.000183	0.00168	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ITGAL—Behcet's disease	0.000179	0.00164	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000177	0.00162	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000175	0.00161	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—APOA1—Behcet's disease	0.000174	0.00159	CbGpPWpGaD
Erlotinib—MKNK1—Disease—SERPINE1—Behcet's disease	0.000173	0.00158	CbGpPWpGaD
Erlotinib—JAK3—Immune System—ICAM1—Behcet's disease	0.000169	0.00155	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—TNF—Behcet's disease	0.000168	0.00154	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000166	0.00152	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—SERPINE1—Behcet's disease	0.000165	0.00151	CbGpPWpGaD
Erlotinib—MKNK1—Disease—NOS3—Behcet's disease	0.000165	0.00151	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—TNF—Behcet's disease	0.000162	0.00149	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—HLA-B—Behcet's disease	0.000156	0.00143	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—TNF—Behcet's disease	0.000155	0.00142	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—APOA1—Behcet's disease	0.000153	0.0014	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000152	0.00139	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000152	0.00139	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—HLA-B—Behcet's disease	0.00015	0.00137	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—APOB—Behcet's disease	0.000145	0.00133	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—CXCL8—Behcet's disease	0.000144	0.00132	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CTLA4—Behcet's disease	0.000144	0.00132	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000139	0.00127	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—SERPINE1—Behcet's disease	0.000138	0.00126	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCR1—Behcet's disease	0.000135	0.00123	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000132	0.00121	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—NOS3—Behcet's disease	0.000132	0.00121	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CXCL8—Behcet's disease	0.000131	0.0012	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CTLA4—Behcet's disease	0.000123	0.00113	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—ICAM1—Behcet's disease	0.000122	0.00112	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—SERPINE1—Behcet's disease	0.000121	0.00111	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.00012	0.0011	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—APOB—Behcet's disease	0.000119	0.00109	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—NOS3—Behcet's disease	0.000116	0.00106	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—APOA1—Behcet's disease	0.000115	0.00105	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—APOB—Behcet's disease	0.000108	0.00099	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000108	0.000989	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HLA-B—Behcet's disease	0.000107	0.000976	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CXCL8—Behcet's disease	0.000103	0.00094	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	9.9e-05	0.000907	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	9.85e-05	0.000901	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—APOA1—Behcet's disease	9.38e-05	0.000859	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—APOB—Behcet's disease	9.36e-05	0.000857	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—SERPINE1—Behcet's disease	9.14e-05	0.000837	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-B—Behcet's disease	9.11e-05	0.000834	CbGpPWpGaD
Erlotinib—EGFR—Disease—APOB—Behcet's disease	9.09e-05	0.000832	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NOS3—Behcet's disease	8.72e-05	0.000799	CbGpPWpGaD
Erlotinib—ABL1—Immune System—ICAM1—Behcet's disease	8.66e-05	0.000793	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CAT—Behcet's disease	8.63e-05	0.00079	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—APOA1—Behcet's disease	8.56e-05	0.000783	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	8.55e-05	0.000782	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—APOB—Behcet's disease	8.37e-05	0.000767	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TNF—Behcet's disease	8.29e-05	0.000759	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	8.2e-05	0.000751	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CAT—Behcet's disease	8.05e-05	0.000737	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	7.83e-05	0.000717	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—APOB—Behcet's disease	7.81e-05	0.000715	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	7.79e-05	0.000713	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CXCL8—Behcet's disease	7.74e-05	0.000709	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	7.65e-05	0.0007	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—SERPINE1—Behcet's disease	7.45e-05	0.000682	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—APOA1—Behcet's disease	7.41e-05	0.000678	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ICAM1—Behcet's disease	7.4e-05	0.000678	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CAT—Behcet's disease	7.32e-05	0.00067	CbGpPWpGaD
Erlotinib—EGFR—Disease—APOA1—Behcet's disease	7.19e-05	0.000658	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NOS3—Behcet's disease	7.11e-05	0.000651	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—APOB—Behcet's disease	7.11e-05	0.000651	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TNF—Behcet's disease	7.09e-05	0.000649	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	6.89e-05	0.000631	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—SERPINE1—Behcet's disease	6.79e-05	0.000622	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—APOA1—Behcet's disease	6.63e-05	0.000607	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	6.49e-05	0.000594	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—NOS3—Behcet's disease	6.48e-05	0.000594	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—APOB—Behcet's disease	6.36e-05	0.000583	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CXCL8—Behcet's disease	6.31e-05	0.000578	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—APOA1—Behcet's disease	6.18e-05	0.000566	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CXCL8—Behcet's disease	5.73e-05	0.000525	CbGpPWpGaD
Erlotinib—EGFR—Disease—SERPINE1—Behcet's disease	5.71e-05	0.000523	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—APOA1—Behcet's disease	5.62e-05	0.000515	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS3—Behcet's disease	5.45e-05	0.000499	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	5.45e-05	0.000499	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CAT—Behcet's disease	5.24e-05	0.00048	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—APOB—Behcet's disease	5.09e-05	0.000466	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—APOA1—Behcet's disease	5.04e-05	0.000461	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—NOS3—Behcet's disease	5.02e-05	0.00046	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CAT—Behcet's disease	4.95e-05	0.000454	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOB—Behcet's disease	4.81e-05	0.00044	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—NOS3—Behcet's disease	4.68e-05	0.000429	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CAT—Behcet's disease	4.54e-05	0.000416	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CAT—Behcet's disease	4.52e-05	0.000414	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOB—Behcet's disease	4.41e-05	0.000404	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOB—Behcet's disease	4.38e-05	0.000401	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—NOS3—Behcet's disease	4.26e-05	0.00039	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—APOA1—Behcet's disease	4.03e-05	0.000369	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SERPINE1—Behcet's disease	4e-05	0.000366	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CAT—Behcet's disease	3.96e-05	0.000362	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOB—Behcet's disease	3.84e-05	0.000352	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOS3—Behcet's disease	3.82e-05	0.000349	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOA1—Behcet's disease	3.81e-05	0.000348	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CAT—Behcet's disease	3.73e-05	0.000341	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOB—Behcet's disease	3.62e-05	0.000331	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOA1—Behcet's disease	3.49e-05	0.000319	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOA1—Behcet's disease	3.47e-05	0.000318	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL8—Behcet's disease	3.39e-05	0.00031	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CAT—Behcet's disease	3.16e-05	0.000289	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOB—Behcet's disease	3.07e-05	0.000281	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NOS3—Behcet's disease	3.05e-05	0.00028	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOA1—Behcet's disease	3.04e-05	0.000278	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NOS3—Behcet's disease	2.88e-05	0.000264	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOA1—Behcet's disease	2.86e-05	0.000262	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NOS3—Behcet's disease	2.64e-05	0.000242	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NOS3—Behcet's disease	2.63e-05	0.000241	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CAT—Behcet's disease	2.44e-05	0.000223	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOA1—Behcet's disease	2.43e-05	0.000222	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOB—Behcet's disease	2.37e-05	0.000217	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NOS3—Behcet's disease	2.3e-05	0.000211	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NOS3—Behcet's disease	2.17e-05	0.000199	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOA1—Behcet's disease	1.87e-05	0.000171	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NOS3—Behcet's disease	1.84e-05	0.000168	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NOS3—Behcet's disease	1.42e-05	0.00013	CbGpPWpGaD
